Pemetu (Pemetreksed disodium) 500 mg/20ml - 100 mg/4ml
Product Description
Onko Ilac Sanayi ve Ticaret A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
Categories
Onko Ilac Sanayi ve Ticaret A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from Onko Ilac Sanayi ve Ticaret A.S. (35)
-
Product Meksratu (Methotrexate PFS) 25mg/ml( 0.3-0.4-0.5-0.6-0.7-0.8-0.9-1.0 ml)
Methotrexate is a chemotherapy agent and immune-system suppressant. It is used to treat cancer, autoimmune diseases, and ectopic pregnancy and for medical abortions -
Product Mextu (Methotrexate) 50 MG/2 ML - 500 MG/20 ML - 1000 MG/40 ML - 5000 MG/50 ML
Methotrexateis a chemotherapy agent and immune-system suppressant. It is used to treat cancer, autoimmune diseases, and ectopic pregnancy and for medical abortions -
Product Misintu 20 mg (Mitomycin)
mitomycin that is used as a chemotherapeutic agent by virtue of its antitumour activity. It is given intravenously to treat upper gastro-intestinal cancers, anal cancers, and breast cancers, as well as by bladder instillation for superficial bladder tumours -
Product Mycophenolate Mofetil 250mg-500mg
Mycophenolate Mofetil is an immunosuppressant medication used to prevent rejection following organ transplantation and to treat autoimmune conditions such as Crohn's disease and lupus. -
Product Oxatu-S (Oxaliplatin) 50MG/10ML - 100 MG/20 ML
Oxaliplatin is a cancer medication used to treat colorectal cancer. Often it is used together with fluorouracil and folinic acid in advanced cancer. It is given by injection into a vein -
Product Pamintu 10mg/10ml (Protamine Sulphate)
Protamine sulfate is a medication that is used to reverse the effects of heparin. It is specifically used in heparin overdose, in low molecular weight heparin overdose, and to reverse the effects of heparin during delivery and heart surgery. It is given by injection into a vein. -
Product Temozolomide 5mg-20mg-100mg-250mg
Temozolomide is a medication used to treat some brain tumors such as glioblastoma multiforme or anaplastic astrocytoma -
Product Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml
Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml is used along with cancer chemotherapy to treat bone damage caused by multiple myeloma or by cancer that began in another part of the body but has spread to the bones. Please contact us for more information. -
Product Bortezomib Onko (Bortezomib), 3.5 mg, Powder for solution for Injection-Vial
Bortezomib Onko (Bortezomib), 3.5 mg, is in Powder for solution for Injection-Vial form. Bortezomib is an antineoplastic agent which is used to treat people with multiple myeloma and mantle cell lymphoma. Contact us for more information. -
Product Azatu (Azacitidine), 100 mg, Powder for Injection Suspension-Vial
Azacitidine,100 mg, Powder for Injection Suspension- Vial is used to treat acute myelogenous leukemia, chronic myelogenous leukemia (CML), myelodysplastic syndrome. Contact us for more information. -
Product Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml
Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml is used along with cancer chemotherapy to treat bone damage caused by multiple myeloma or by cancer that began in another part of the body but has spread to the bones. Please contact us for more information.
... -
Product Kopaq (Iohexol), Concentrated Solution for Injection - Vial, 300 mgI/ml (50 ml), 300 mgI/ml (100 ml), 350 mgl/ml (50 ml), 350 mgl/ml (100 ml), 350 mgl/ml (200 ml)
Kopaq (Iohexol), Concentrated Solution for Injection - Vial, 300 mgI/ml (50 ml), 300 mgI/ml (100 ml), 350 mgl/ml (50 ml), 350 mgl/ml (100 ml), 350 mgl/ml (200 ml) is a iodinated, nonionic, low osmolar contrast agent.The product is used in arthrography, endoscopic retrograde pancreatography (ERP), endoscopi...
Onko Ilac Sanayi ve Ticaret A.S. resources (2)
-
News Bortezomib Injection 3.5 mg vial DCP application
Onko Koçsel is proud that Bortezomib Injection 3.5 mg vial DCP application has been successfully accepted by EMA member countries on March, 2021. Onko Koçsel is open for collaboration within and outside EU countries.
-
Video Onko Kocsel Factory video
Onko Kocsel Factory video
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance